Abano flags capital return after sale of National Hearing stake
Abano Healthcare is mulling options to return capital to shareholders after making a profit on the sale of its stake in Australia's National Hearing Care.
Abano will reap about $26 million cash from the sale of its holding in NHC, which is being sold by Crescent Capital to Amplifon Group for a total of A$460 million. Abano owned 13% jointly with Peter Hutson, the founder of Bay Audiology, which was acquired by NHC. Before repayment of debt and other costs, the stake was worth $58 million.
"Given the size of the capital return from the NHC sale, the board is currently reviewing options to return capital to shareholders, including the previously indicated on-market share buy-back," said managing director Alan Clarke.
The cash proceeds of the NHC sale are expected in late December and any return would be in the New Year, he said.
Some of the money will be used for new investments, such as dental clinics in New Zealand and Australia, audiology in Australia and Asia and radiology in New Zealand, he said.
The shares fell 4 cents to $5.20 yesterday and has fallen 16% this year.
Comments from our readers
No comments yet
Add your comment:
Abano forecasts FY sales growth up to 1.3 percent , jump in net profit
Abano posts 1H profit of $1.5M, meeting guidance; shares gain
Abano forecasts 1H sales growth, profit similar range to last year
Abano's bottom line fell sharply but results at top end of forecasts
Abano 1H profit tumbles 53%
Abano first-half profit falls on expansion costs; sales rise
New Deputy Chair for Abano
Abano flags softer bottom line in first-half on charges; revenue climbs
New Chairman for Abano Healthcare Group